Ուռուցքի քայքայման համախտանիշ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ուռուցքի քայքայման համախտանիշ" in Armenian language version.

refsWebsite

Global rank Armenian rank

14nih.gov

4^th place

3^rd place

12doi.org

2^nd place

4^th place

3archive.org

6^th place

2worldcat.org

5^th place

10^th place

1handle.net

102^nd place

2,318^th place

1books.google.com

3^rd place

17^th place

1jco.org

low place

archive.org (Global: 6^th place; Armenian: 6^th place)

Cairo MS, Bishop M (2004 թ․ հոկտեմբեր). «Tumour lysis syndrome: new therapeutic strategies and classification». Br. J. Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.
Howard, SC; Jones, DP; Pui, CH (2011 թ․ մայիսի 12). «The tumor lysis syndrome». The New England Journal of Medicine. 364 (19): 1844–54. doi:10.1056/NEJMra0904569. PMC 3437249. PMID 21561350.
Mayne N, Keady S, Thacker M (2008 թ․ փետրվար). «Rasburicase in the prevention and treatment of tumour lysis syndrome». Intensive Crit Care Nurs. 24 (1): 59–62. doi:10.1016/j.iccn.2007.06.002. PMID 17698360.

books.google.com (Global: 3^rd place; Armenian: 17^th place)

A. R. Moossa; Stephen C. Schimpff; Martin C. Robson (1991). Comprehensive textbook of oncology, Volume 2. Lippincott Williams & Wilkins. ISBN 9780683061475. Վերցված է 2012 թ․ մայիսի 2-ին. «... result in severe metabolic derangements (e.g., hyperuricemia, hypocalcemia, lactic aci- dosis, and the acute tumor lysis syndrome) which require expeditious management. Hyperuricemia Uric acid is the end product of purine catabolism.»

doi.org (Global: 2^nd place; Armenian: 4^th place)

Davidson MB, Thakkar S, Hix JK, Bhandarkar MD, Wong A, Schreiber MJ (2004 թ․ ապրիլ). «Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome». Am. J. Med. 116 (8): 546–54. doi:10.1016/j.amjmed.2003.09.045. PMID 15063817.
Cheuk, DK; Chiang, AK; Chan, GC; Ha, SY (2014 թ․ օգոստոսի 14). «Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer». The Cochrane Database of Systematic Reviews. 8 (8): CD006945. doi:10.1002/14651858.CD006945.pub3. hdl:10722/218800. PMID 25121561.
Rampello E, Fricia T, Malaguarnera M (2006 թ․ օգոստոս). «The management of tumor lysis syndrome». Nat Clin Pract Oncol. 3 (8): 438–47. doi:10.1038/ncponc0581. PMID 16894389.
Darmon, Michael; Malak, Sandra; Guichard, Isabelle; Schlemmer, Benoit (July–September 2008). «Acute tumor lysis syndrome: a comprehensive review». Revista Brasileira de Terapia Intensiva. 20 (3): 278–285. doi:10.1590/S0103-507X2008000300011. ISSN 0103-507X.
Weeks, A. C.; Kimple, M. E. (2015 թ․ օգոստոսի 26). «Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens». Journal of Investigative Medicine High Impact Case Reports. 3 (3): 232470961560319. doi:10.1177/2324709615603199. PMC 4748506. PMID 26904699.
Coiffier, Bertrand; Riouffol, Catherine (2007 թ․ փետրվարի 1). «Management of tumor lysis syndrome in adults». Expert Review of Anticancer Therapy. 7 (2): 233–239. doi:10.1586/14737140.7.2.233. ISSN 1473-7140. PMID 17288532.
d'Alessandro, V.; Greco, A.; Clemente, C.; Sperandeo, M.; De Cata, A.; Di Micco, C.; Maiello, E.; Vendemiale, G. (2010). «Severe spontaneous acute tumor lysis syndrome and hypoglycemia in patient with germ cell tumor». Tumori. 96 (6): 1040–1043. doi:10.1177/548.6530. PMID 21388073.
Cairo MS, Bishop M (2004 թ․ հոկտեմբեր). «Tumour lysis syndrome: new therapeutic strategies and classification». Br. J. Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.
Howard, SC; Jones, DP; Pui, CH (2011 թ․ մայիսի 12). «The tumor lysis syndrome». The New England Journal of Medicine. 364 (19): 1844–54. doi:10.1056/NEJMra0904569. PMC 3437249. PMID 21561350.
Mayne N, Keady S, Thacker M (2008 թ․ փետրվար). «Rasburicase in the prevention and treatment of tumour lysis syndrome». Intensive Crit Care Nurs. 24 (1): 59–62. doi:10.1016/j.iccn.2007.06.002. PMID 17698360.
Coiffier B, Mounier N, Bologna S, և այլք: (2003 թ․ դեկտեմբեր). «Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study». J. Clin. Oncol. 21 (23): 4402–6. doi:10.1200/JCO.2003.04.115. PMID 14581437.(չաշխատող հղում)
Cammalleri L, Malaguarnera M (2007). «Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout». Int J Med Sci. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.

handle.net (Global: 102^nd place; Armenian: 2,318^th place)

hdl.handle.net

Cheuk, DK; Chiang, AK; Chan, GC; Ha, SY (2014 թ․ օգոստոսի 14). «Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer». The Cochrane Database of Systematic Reviews. 8 (8): CD006945. doi:10.1002/14651858.CD006945.pub3. hdl:10722/218800. PMID 25121561.

jco.org (Global: low place; Armenian: low place)

Coiffier B, Mounier N, Bologna S, և այլք: (2003 թ․ դեկտեմբեր). «Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study». J. Clin. Oncol. 21 (23): 4402–6. doi:10.1200/JCO.2003.04.115. PMID 14581437.(չաշխատող հղում)

nih.gov (Global: 4^th place; Armenian: 3^rd place)

pubmed.ncbi.nlm.nih.gov

Davidson MB, Thakkar S, Hix JK, Bhandarkar MD, Wong A, Schreiber MJ (2004 թ․ ապրիլ). «Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome». Am. J. Med. 116 (8): 546–54. doi:10.1016/j.amjmed.2003.09.045. PMID 15063817.
Cheuk, DK; Chiang, AK; Chan, GC; Ha, SY (2014 թ․ օգոստոսի 14). «Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer». The Cochrane Database of Systematic Reviews. 8 (8): CD006945. doi:10.1002/14651858.CD006945.pub3. hdl:10722/218800. PMID 25121561.
Rampello E, Fricia T, Malaguarnera M (2006 թ․ օգոստոս). «The management of tumor lysis syndrome». Nat Clin Pract Oncol. 3 (8): 438–47. doi:10.1038/ncponc0581. PMID 16894389.
Weeks, A. C.; Kimple, M. E. (2015 թ․ օգոստոսի 26). «Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens». Journal of Investigative Medicine High Impact Case Reports. 3 (3): 232470961560319. doi:10.1177/2324709615603199. PMC 4748506. PMID 26904699.
Coiffier, Bertrand; Riouffol, Catherine (2007 թ․ փետրվարի 1). «Management of tumor lysis syndrome in adults». Expert Review of Anticancer Therapy. 7 (2): 233–239. doi:10.1586/14737140.7.2.233. ISSN 1473-7140. PMID 17288532.
d'Alessandro, V.; Greco, A.; Clemente, C.; Sperandeo, M.; De Cata, A.; Di Micco, C.; Maiello, E.; Vendemiale, G. (2010). «Severe spontaneous acute tumor lysis syndrome and hypoglycemia in patient with germ cell tumor». Tumori. 96 (6): 1040–1043. doi:10.1177/548.6530. PMID 21388073.
Cairo MS, Bishop M (2004 թ․ հոկտեմբեր). «Tumour lysis syndrome: new therapeutic strategies and classification». Br. J. Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.
Howard, SC; Jones, DP; Pui, CH (2011 թ․ մայիսի 12). «The tumor lysis syndrome». The New England Journal of Medicine. 364 (19): 1844–54. doi:10.1056/NEJMra0904569. PMC 3437249. PMID 21561350.
Mayne N, Keady S, Thacker M (2008 թ․ փետրվար). «Rasburicase in the prevention and treatment of tumour lysis syndrome». Intensive Crit Care Nurs. 24 (1): 59–62. doi:10.1016/j.iccn.2007.06.002. PMID 17698360.
Coiffier B, Mounier N, Bologna S, և այլք: (2003 թ․ դեկտեմբեր). «Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study». J. Clin. Oncol. 21 (23): 4402–6. doi:10.1200/JCO.2003.04.115. PMID 14581437.(չաշխատող հղում)
Cammalleri L, Malaguarnera M (2007). «Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout». Int J Med Sci. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.

ncbi.nlm.nih.gov

Weeks, A. C.; Kimple, M. E. (2015 թ․ օգոստոսի 26). «Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens». Journal of Investigative Medicine High Impact Case Reports. 3 (3): 232470961560319. doi:10.1177/2324709615603199. PMC 4748506. PMID 26904699.
Howard, SC; Jones, DP; Pui, CH (2011 թ․ մայիսի 12). «The tumor lysis syndrome». The New England Journal of Medicine. 364 (19): 1844–54. doi:10.1056/NEJMra0904569. PMC 3437249. PMID 21561350.
Cammalleri L, Malaguarnera M (2007). «Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout». Int J Med Sci. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.

worldcat.org (Global: 5^th place; Armenian: 10^th place)

Darmon, Michael; Malak, Sandra; Guichard, Isabelle; Schlemmer, Benoit (July–September 2008). «Acute tumor lysis syndrome: a comprehensive review». Revista Brasileira de Terapia Intensiva. 20 (3): 278–285. doi:10.1590/S0103-507X2008000300011. ISSN 0103-507X.
Coiffier, Bertrand; Riouffol, Catherine (2007 թ․ փետրվարի 1). «Management of tumor lysis syndrome in adults». Expert Review of Anticancer Therapy. 7 (2): 233–239. doi:10.1586/14737140.7.2.233. ISSN 1473-7140. PMID 17288532.

Ուռուցքի քայքայման համախտանիշ (Armenian Wikipedia)

archive.org (Global: 6th place; Armenian: 6th place)

books.google.com (Global: 3rd place; Armenian: 17th place)

doi.org (Global: 2nd place; Armenian: 4th place)

handle.net (Global: 102nd place; Armenian: 2,318th place)